Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|March 21, 2015
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II studyEmilio Iannitto, Stefano Luminari, Claudio Tripodo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Paolo G Gobbi, et al.
Investigational New Drugs|April 28, 2019
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphomaM Christina Cox, Sabrina Pelliccia, Luigi Marcheselli, et al.
Hematological Oncology|April 2, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL StudyFrancesca Maria Quaglia, Lara Mannelli, Luca Pagliaro, et al.
Haematologica|November 21, 2007
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL studyMassimo Federico, Cesare Guglielmi, Stefano Luminari, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significanceFrancesca Rossi, Maria Teresa Petrucci, Andrea Guffanti, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2019
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapyMassimiliano Salati, Francesco Caputo, David Cunningham, et al.
Leukemia & Lymphoma|July 22, 2016
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II studySamantha Pozzi, Massimo Gentile, Stefano Sacchi, et al.
Pageof 13